- Home
- ZYME vs TRST Comparison
ZYME vs TRST Comparison
Compare ZYME & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYME
- TRST
- Stock Information
- Founded
- ZYME 2003
- TRST 1902
- Country
- ZYME United States
- TRST United States
- Employees
- ZYME 286
- TRST N/A
- Industry
- ZYME Biotechnology: Pharmaceutical Preparations
- TRST Major Banks
- Sector
- ZYME Health Care
- TRST Finance
- Exchange
- ZYME Nasdaq
- TRST Nasdaq
- Market Cap
- ZYME 739.6M
- TRST 624.8M
- IPO Year
- ZYME 2017
- TRST N/A
- Fundamental
- Price
- ZYME $11.53
- TRST $28.52
- Analyst Decision
- ZYME Buy
- TRST
- Analyst Count
- ZYME 6
- TRST 0
- Target Price
- ZYME $19.50
- TRST N/A
- AVG Volume (30 Days)
- ZYME 833.8K
- TRST 108.5K
- Earning Date
- ZYME 05-08-2025
- TRST 04-21-2025
- Dividend Yield
- ZYME N/A
- TRST 5.04%
- EPS Growth
- ZYME N/A
- TRST N/A
- EPS
- ZYME N/A
- TRST 2.57
- Revenue
- ZYME $76,304,000.00
- TRST $169,773,000.00
- Revenue This Year
- ZYME $26.29
- TRST $13.13
- Revenue Next Year
- ZYME $75.78
- TRST N/A
- P/E Ratio
- ZYME N/A
- TRST $11.11
- Revenue Growth
- ZYME 0.38
- TRST N/A
- 52 Week Low
- ZYME $7.97
- TRST $25.85
- 52 Week High
- ZYME $17.70
- TRST $38.89
- Technical
- Relative Strength Index (RSI)
- ZYME 49.31
- TRST 41.22
- Support Level
- ZYME $10.69
- TRST $27.18
- Resistance Level
- ZYME $11.48
- TRST $29.27
- Average True Range (ATR)
- ZYME 0.78
- TRST 1.27
- MACD
- ZYME 0.10
- TRST -0.00
- Stochastic Oscillator
- ZYME 81.57
- TRST 37.85
About ZYME Zymeworks Inc.
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
About TRST TrustCo Bank Corp NY
Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.